The Lung Tumour Committee is made up of a multidisciplinary team of professionals in: medical oncology, thoracic surgery, radiation oncology, pneumology, radiodiagnosis, interventional radiology, nuclear medicine, radiophysics, pathological anatomy, molecular biology, physiotherapy, psychology, nursing, and home hospitalisation.
The treatment of a tumour will depend on its typology, extension, and evolution. Depending on each case, there are therapeutic options available for surgery, external or internal radiotherapy (brachytherapy), or systemic treatments (chemotherapy, hormone therapy, drugs against molecular targets, etc.), and/or combinations of these.
This occurs when cancer cells originate in the lungs and can grow to affect the surrounding structures. Depending on their initial location, these may be the ribs, heart, great vessels, oesophagus, or vertebral bodies.
The IVO has the Early Detection Unit called IELCAP, where the early diagnosis of asymptomatic lung cancer in people at risk (over 50 years old and with a smoking habit of more than 15 years) is carried out through the performance and periodic study of a multislice CT scan.
Services included in this committee
The Tumour Committees are regulated under established protocols and are made up of a multidisciplinary team of expert doctors from the main specialities depending on the type of tumour. The IVO’s breast tumour committee is made up of multidisciplinary medical teams from the following specialities:
